Every aSAH trial that reports DCI as an outcome uses a definition Mervyn Vergouwen first-authored.
Former ISAH convener. Now joins #ISAH2026 — Sydney, Nov 17–20.
🔗 https://t.co/i0MNzWFZQQ
How aggressively should you transfuse after SAH?
We now have an answer.
Shane English ran the NEJM trial to find out — joins #ISAH2026, Sydney, Nov 17–20
🔗 https://t.co/EDMDaY1bKA
Former Editor-in-Chief, Intensive Care Medicine. 500+ publications. H-index 61.
Giuseppe Citerio joins #ISAH2026 — Sydney, Nov 17–20.
🔗 https://t.co/EDMDaY1bKA
We asked José Suarez - Past President, NCS; Founding Chair, NCRN - why he's coming to #ISAH2026.
"The latest treatments, what the future holds — and of course, beautiful Sydney."
We'll take it!
Sydney, Nov 17–20
🔗 https://t.co/i0MNzWFZQQ
Throwback to 2013 - a Pecha Kucha on aSAH complications: non-convulsive seizures, neurogenic cardiomyopathy, CSW vs SIADH, rebleeding, hydrocephalus. Old video, still holds up. These debates belong at #ISAH2026 (https://t.co/DgFaBgZCh0). 🎬 https://t.co/8GEKd3sUXp
Almost a year ago I interviewed an AI (Simon, GPT-4o) about vasospasm & DCI in aSAH. AI has moved fast - but Simon was on it. Worth a revisit. These debates are what #ISAH2026 is for. 🎙️ https://t.co/Aj2sTHawuT https://t.co/DgFaBgZCh0
Were we measuring the wrong things in DCI trials? Or is the biology more complicated than we thought? Probably both.
Jose Suarez (Johns Hopkins) on what needs to change before the next trial.
ISAH 2026 | Sydney | 17–20 Nov
https://t.co/DgFaBgZCh0
#DCI#SAH#ISAH2026
We understand DCI better than ever.
We still can't reliably treat it.
That gap is exactly what #ISAH2026 is for.
R. Loch Macdonald | Sydney, Nov 17–20
🔗https://t.co/EDMDaY1bKA
PROTECT-U. ESO guidelines. Convener of ISAH 2019.
Nima Etminan has spent his career asking what we should actually do when we find an aneurysm.
Supporting #ISAH2026 - Sydney, Nov 17–20.
https://t.co/EDMDaY1bKA
"Practice-changing things that maybe aren't guideline ready — but get us ready for the next version."
That's @NerissaKoMD on why ISAH matters. We'll take it.
Sydney. November. https://t.co/i0MNzWFZQQ
#ISAH2026#aSAH@NeurosurgUCSF
This aSAH PechaKucha is 12+ years old. The emergency framework holds. The 2012 guidelines don't. TXA and coiling-vs-clipping have both moved on.
Sharing it as a warm-up — ISAH 2026 is running a PK competition. Best entries present in Sydney.
▶️ https://t.co/e9sRDUdXzD
#ISAH26
Founding editor of the Journal of NeuroInterventional Surgery. Past SNIS president. 450+ publications.
@JoshuaAHirsch at #ISAH2026 - the global SAH forum.
📍 Sydney | Nov 17–20
https://t.co/EDMDaY1bKA
Jose Suarez on what he would NOT do in a DCI trial: choose one medication with one mechanism of action. "We'll just be replicating the same failures."
It's a short answer. The implications aren't.
ISAH 2026 | Sydney | 17–20 Nov
https://t.co/DgFaBgZCh0 #ISAH26
525+ peer-reviewed papers. 2 dozen trials. Still asking whether we're treating the right aneurysms.
J Mocco joins #ISAH2026
📍 Sydney | Nov 17–20
https://t.co/wjzygbMIdC
SAH guidelines have an RCT purity problem.
Nerissa Ko (UCSF): for rare, variable diseases, holding out for trials that may never come isn't rigour - it's stasis.
📍 ISAH 2026 | Nov, Sydney
🔗 https://t.co/i0MNzWFZQQ
#ISAH2026#aSAH